文献速递肝病

饮酒类型与模式与非酒精性脂肪性肝病患者肝纤维化相关

Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease.
PubMed 文献 · Am J Gastroenterol · 2018-06-14

在187例接受肝活检的非酒精性脂肪性肝病(NAFLD)患者中,每周少量饮酒(1-70克)与较低的纤维化分期和晚期纤维化风险降低相关(OR 0.33,95%CI 0.14-0.78,p=0.01),但该关联仅见于非狂饮模式及仅饮葡萄酒者;需前瞻性纵向研究后才能给出临床推荐。

要点

  • 每周少量饮酒(1-70克)与晚期纤维化风险降低相关(OR 0.33,95%CI 0.14-0.78,p=0.01)。
  • 狂饮模式饮酒者未观察到纤维化降低的关联。
  • 仅饮葡萄酒者晚期纤维化风险降低(OR 0.20,95%CI 0.06-0.69,p=0.01),仅饮啤酒者无此关联。

核心结论

  • 每周少量(1-70克)饮酒,尤其是非狂饮模式的葡萄酒,与NAFLD患者较低的纤维化相关。
  • 在给出临床推荐前,需要开展关于纤维化进展、心血管结局和死亡率的前瞻性纵向研究。

研究设计与样本

  • 对接受肝活检的NAFLD患者评估既往和当前饮酒情况,所有受试者当前饮酒量低于每周210克(男性)或低于每周140克(女性)。
  • 狂饮定义为一次坐席饮酒中女性≥4个标准杯或男性≥5个标准杯。
  • 肝活检按NASH CRN系统评分,F3/4纤维化定义为晚期纤维化。

主要发现

  • 187例患者中24%有晚期纤维化,中位每周饮酒量为20(2.3-60)克,平均饮酒年限18年。
  • 与终身戒酒者相比,少量饮酒(每周1-70克)与较低的平均纤维化分期相关(p<0.05),并与晚期纤维化风险降低相关(OR 0.33,95%CI 0.14-0.78,p=0.01)。
  • 狂饮模式饮酒者未观察到纤维化降低的关联。
  • 与终身戒酒者相比,仅饮葡萄酒者平均纤维化分期较低且晚期纤维化风险降低(OR 0.20,95%CI 0.06-0.69,p=0.01),仅饮啤酒者无此关联。
  • 未观察到性别与饮酒量、类型或狂饮模式对纤维化的交互作用。

临床怎么用

  • 原文未据此给出临床推荐,作者指出在给出临床推荐前需要关于纤维化进展、心血管结局和死亡率的前瞻性纵向研究。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: It is unclear whether low levels of alcohol are harmful in patients with non-alcoholic fatty liver disease (NAFLD). We aimed to determine whether quantity, binge pattern consumption, or type of alcohol was associated with liver fibrosis in patients with NAFLD. METHODS: Previous and current alcohol consumption was assessed in NAFLD patients undergoing liver biopsy. All subjects currently consumed <210 g per week (male) or <140 g per week (female). Binge consumption was defined as ≥4 standard drinks (female) or ≥5 standard drinks (male) in one sitting. Liver biopsies were scored according to the NASH CRN system with F3/4 fibrosis defined as advanced. RESULTS: Among 187 patients (24% with advanced fibrosis), the median weekly alcohol consumption was 20 (2.3-60) g over an average of 18 years. Modest consumption (1-70 g per week) was associated with lower mean fibrosis stage compared to lifetime abstainers (p < 0.05) and a decreased risk of advanced fibrosis (OR 0.33, 95% CI 0.14-0.78, p = 0.01). The association with reduced fibrosis was not seen in subjects drinking in a binge-type fashion. Exclusive wine drinkers but not exclusive beer drinkers, had lower mean fibrosis stage and lower odds of advanced fibrosis (OR 0.20, 95% CI 0.06-0.69, p = 0.01), compared to lifetime abstinent subjects. No interaction between gender and alcohol quantity, type, or binge consumption on fibrosis was observed. DISCUSSION: Modest (1-70 g per week) alcohol consumption, particularly wine in a non-binge pattern, is associated with lower fibrosis in patients with NAFLD. Prospective longitudinal studies into fibrosis progression, cardiovascular outcomes, and mortality are required before clinical recommendations can be made.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Mitchell T, Jeffrey GP, de Boer B, et al. Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. Am J Gastroenterol. 2018. PMID: 29899440. doi:10.1038/s41395-018-0133-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。